Literature DB >> 21468544

Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells.

Chul Jang Kim1, Kanami Sakamoto, Yukihiro Tambe, Hirokazu Inoue.   

Abstract

We previously showed that periostin expression is downregulated in human bladder cancer tissues and that ectopic expression of periostin suppresses the invasiveness of bladder cancer cells. However, in most other human cancers studied, the expression of periostin promotes cell invasiveness. In the present study, we investigated the regulation of the epithelial-to-mesenchymal transition (EMT) and cell invasiveness by periostin in bladder and prostate cancer cell lines, and found opposite regulation of EMT and cell invasiveness by periostin. Periostin upregulated E-cadherin expression in bladder cancer cells but downregulated it in prostate cancer cells. Periostin suppressed cell invasiveness in bladder cancer cells but promoted it in prostate cancer cells. Snail, a negative regulator of E-cadherin, was upregulated by periostin in prostate cancer cells, while Twist, another negative regulator of E-cadherin, was downregulated in bladder cancer cells. The C-terminal region of periostin was sufficient for these functions in bladder cancer cells but not in prostate cancer cells. Knockdown of endogenous Snail by siRNA suppressed cell invasiveness in prostate cancer cells expressing periostin. Periostin also suppressed Akt phosphorylation in bladder cancer cells but enhanced it in prostate cancer cells. Treatment with Akt inhibitor increased E-cadherin expression and suppressed both Twist expression and cell invasiveness of bladder cancer cells. These results indicate that Akt signaling plays a role in the cell-type-dependent regulation of E-cadherin expression and cell invasiveness by periostin via Snail and Twist.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468544     DOI: 10.3892/ijo.2011.997

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  32 in total

1.  Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models.

Authors:  Soon Young Park; Yuji Piao; Kang Jin Jeong; Jianwen Dong; John F de Groot
Journal:  Mol Cancer Ther       Date:  2016-06-15       Impact factor: 6.261

2.  Association between periostin and epithelial-mesenchymal transition in esophageal squamous cell carcinoma and its clinical significance.

Authors:  Ya-Jing Lv; Wei Wang; Chu-Shu Ji; Ming-Ran Xie; Bing Hu
Journal:  Oncol Lett       Date:  2017-05-05       Impact factor: 2.967

Review 3.  Tissue remodeling in eosinophilic esophagitis.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart J Spechler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-27       Impact factor: 4.052

4.  Distinct expression pattern of periostin splice variants in chondrocytes and ligament progenitor cells.

Authors:  Lei Cai; Robert H Brophy; Eric D Tycksen; Xin Duan; Ryan M Nunley; Muhammad Farooq Rai
Journal:  FASEB J       Date:  2019-04-16       Impact factor: 5.191

5.  Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.

Authors:  Hongjun Lv; Rui Liu; Jiao Fu; Qi Yang; Jing Shi; Pu Chen; Meiju Ji; Bingyin Shi; Peng Hou
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 6.  The role of Snail in prostate cancer.

Authors:  Bethany N Smith; Valerie A Odero-Marah
Journal:  Cell Adh Migr       Date:  2012-09-01       Impact factor: 3.405

Review 7.  Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis.

Authors:  Hae-Yun Jung; Laurent Fattet; Jing Yang
Journal:  Clin Cancer Res       Date:  2014-08-08       Impact factor: 12.531

8.  High-level expression of periostin is significantly correlated with tumour angiogenesis and poor prognosis in osteosarcoma.

Authors:  Fei Hu; Xi-Fu Shang; Wei Wang; Wei Jiang; Ce Fang; Dong Tan; Hang-Cheng Zhou
Journal:  Int J Exp Pathol       Date:  2016-03-30       Impact factor: 1.925

9.  Role of SMAD4 in the mechanism of valproic acid's inhibitory effect on prostate cancer cell invasiveness.

Authors:  Wei Jiang; Yi Zheng; Zhongxian Huang; Muwen Wang; Yinan Zhang; Zheng Wang; Xunbo Jin; Qinghua Xia
Journal:  Int Urol Nephrol       Date:  2013-11-22       Impact factor: 2.370

Review 10.  A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition.

Authors:  Wenting Xu; Zhen Yang; Nonghua Lu
Journal:  Cell Adh Migr       Date:  2015-08-04       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.